Todd S.  Young net worth and biography

Todd Young Biography and Net Worth

Todd S. Young holds the position of CFO & EVP-Corporate Governance & Strategy at Elanco Animal Health, Inc.

He previously occupied the position of Executive VP, Chief Financial & Accounting Officer at ACADIA Pharmaceuticals, Inc., Treasurer & Vice President of Baxter International, Inc., Tax Attorney at Sidley & Austin and Senior Vice President at Baxalta, Inc.

Todd S. Young received an undergraduate degree from Grinnell College and a graduate degree from The University of Michigan Law School.

What is Todd S. Young's net worth?

The estimated net worth of Todd S. Young is at least $482,796.19 as of August 3rd, 2020. Mr. Young owns 41,513 shares of Elanco Animal Health stock worth more than $482,796 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Young may own. Additionally, Mr. Young receives a salary of $1,110,000.00 as Insider at Elanco Animal Health. Learn More about Todd S. Young's net worth.

How old is Todd S. Young?

Mr. Young is currently 52 years old. There are 6 older executives and no younger executives at Elanco Animal Health. The oldest executive at Elanco Animal Health is Dr. Ellen de Brabander Ph.D., Executive Vice President of Research, Development & Regulatory Affairs, who is 61 years old. Learn More on Todd S. Young's age.

What is Todd S. Young's salary?

As the Insider of Elanco Animal Health Incorporated, Mr. Young earns $1,110,000.00 per year. There are 3 executives that earn more than Mr. Young. The highest earning executive at Elanco Animal Health is Mr. Jeffrey N. Simmons, President & CEO, who commands a salary of $2,460,000.00 per year. Learn More on Todd S. Young's salary.

How do I contact Todd S. Young?

The corporate mailing address for Mr. Young and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Todd S. Young's contact information.

Has Todd S. Young been buying or selling shares of Elanco Animal Health?

Todd S. Young has not been actively trading shares of Elanco Animal Health during the past quarter. Most recently, on Monday, August 3rd, Todd S. Young bought 7,000 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $23.91 per share, with a total value of $167,370.00. Following the completion of the transaction, the insider now directly owns 41,513 shares of the company's stock, valued at $992,575.83. Learn More on Todd S. Young's trading history.

Who are Elanco Animal Health's active insiders?

Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Rajeev Modi (Insider), Jeffrey Simmons (President & CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.

Are insiders buying or selling shares of Elanco Animal Health?

During the last year, Elanco Animal Health insiders bought shares 4 times. They purchased a total of 138,500 shares worth more than $1,930,475.00. The most recent insider tranaction occured on August, 22nd when Director Michael J Harrington bought 3,500 shares worth more than $51,975.00. Insiders at Elanco Animal Health own 0.6% of the company. Learn More about insider trades at Elanco Animal Health.

Information on this page was last updated on 8/22/2024.

Todd S. Young Insider Trading History at Elanco Animal Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2020Buy7,000$23.91$167,370.0041,513View SEC Filing Icon  
9/4/2019Buy10,000$26.57$265,700.0028,883View SEC Filing Icon  
See Full Table

Todd S. Young Buying and Selling Activity at Elanco Animal Health

This chart shows Todd S Young's buying and selling at Elanco Animal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elanco Animal Health Company Overview

Elanco Animal Health logo
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Read More

Today's Range

Now: $11.63
Low: $11.63
High: $12.19

50 Day Range

MA: $12.96
Low: $11.63
High: $14.50

2 Week Range

Now: $11.63
Low: $11.40
High: $18.80

Volume

9,435,554 shs

Average Volume

4,797,913 shs

Market Capitalization

$5.75 billion

P/E Ratio

29.08

Dividend Yield

N/A

Beta

1.41